Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B

OBJECTIVE: To delineate the rate and duration of transient hepatitis B surface antigenemia following Heplisav-B vaccination. PATIENTS AND METHODS: We retrospectively reviewed the medical records of all adult patients who received Heplisav-B vaccination at our institution from January 1, 2019, throug...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mayo Clin Proc Innov Qual Outcomes
Autors principals: Corsini Campioli, Cristina, Esquer Garrigos, Zerelda, Assi, Mariam, Go, John Raymond, Razonable, Raymund R., Beam, Elena, Yao, Joseph, Cummins, Nathan W.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8240146/
https://ncbi.nlm.nih.gov/pubmed/34195546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2020.10.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars